INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
ISSN:0268-1315

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

INT CLIN PSYCHOPHARM
学科领域:医学
是否预警:不在预警名单内
是否OA:
录用周期:>12周,或约稿
新锐分区:医学3区
年发文量:42
影响因子:2.5
JCR分区:Q2

基本信息

国际临床精神药理学提供了整个精神药理学研究和临床实践之间的重要联系。它报道了在健康志愿者和病人中进行的研究,这些研究涉及药物对心理过程的影响。该杂志的一个主要目标是发表经过充分审阅的论文,这些论文揭示了精神药物研究可以增加我们对精神药理学的理解的方式。为此,该杂志发表早期I期和II期研究的结果,以及II期和IV期精神药物的对照临床试验的结果。其他涵盖的主题包括精神药物处方和药物服用的流行病学,精神药物的社会学,包括依从性,以及对这些化合物的安全性和副作用的研究。
0268-1315SCIE/Scopus收录
2.5
2.5
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
PHARMACOLOGY & PHARMACY 药学
3区
PSYCHIATRY 精神病学
4区
N/A
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科:PHARMACOLOGY & PHARMACY
SCIE
Q3
181/352
学科:PSYCHIATRY
SCIE
Q2
130/288
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科:PHARMACOLOGY & PHARMACY
SCIE
Q2
159/353
学科:PSYCHIATRY
SCIE
Q3
148/288
85
42
3%较易>12周,或约稿-医学-精神病学
24%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
85.71%24.62%2.22%
CiteScore:4.60
SJR:0.642
SNIP:0.625
学科类别分区排名百分位
大类:Medicine
小类:Psychiatry and Mental Health
Q2
210 / 580
大类:Medicine
小类:Pharmacology (medical)
Q2
113 / 275

期刊高被引文献

Markers of mineralocorticoid receptor function: changes over time and relationship to response in patients with major depression
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000239
Long-acting injectable second-generation antipsychotics in first-episode psychosis: a narrative review
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000249
Effectiveness and safety of long-term benzodiazepine use in anxiety disorders: a systematic review and meta-analysis.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000276
Analysis of smoking behavior on the pharmacokinetics of antidepressants and antipsychotics: evidence for the role of alternative pathways apart from CYP1A2
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000250
Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000248
The risk factors, frequency and diagnosis of atypical antipsychotic drug-induced hypothermia: practical advice for doctors
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000244
Proinflammatory and anti-inflammatory biomarkers in schizophrenia and influence of simvastatin on the interleukin-6
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000241
Personalized and precision medicine as informants for treatment management of bipolar disorder.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000260
OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000290
Hyoscine for clozapine-induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000251
Cytochrome P450-mediated inhibition of venlafaxine metabolism by trimipramine.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000268
The association between gabapentin and suicidality in bipolar patients
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000242
Antipsychotics in the general population and the driver population: comparisons from a population-based registry study.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000263
Sexual dysfunction in tramadol Hydrochloride use disorder male patients: a case-control study.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000286
Effect of N-acetylcysteine on clozapine-induced sialorrhea in schizophrenic patients: a case series
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000297
Long-term effects of paliperidone palmitate on hospital stay and treatment continuation.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000285
Add-on benzodiazepines for psychosis-induced aggression
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000254
Association between previous high-dose antipsychotic therapy and brexpiprazole discontinuation after the initiation of brexpiprazole in patients with schizophrenia or schizoaffective disorder
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000296
Plasma levels of 3-methoxy-4-hydroxyphenylglycol levels, number of hospitalization and cognitive function predicts the cognitive effect of atypical antipsychotic monotherapy in patients with acute schizophrenia
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000293
Effects of medications on ventricular repolarization in children with attention deficit hyperactivity disorder
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000288
Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000246
Metabolism of risperidone by CYP2D6 and the presence of drug-induced dopamine supersensitivity psychosis in patients with schizophrenia
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000257
Effects of Passiflora incarnata Linnaeus on polysomnographic sleep parameters in subjects with insomnia disorder: a double-blind randomized placebo-controlled study.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000291
Rapid improvement of obsessive-compulsive disorder associated with schizophrenia with cariprazine add-on in a subject under paliperidone long-acting injection: a case report.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000284
Pharmacological treatment of attention-deficit hyperactivity disorder comorbid with an anxiety disorder: a systematic review
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000243
Compliance in schizophrenia spectrum disorders: the role of clinical pharmacist.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000280
The unmasking of hidden severe hyponatremia after long-term combination therapy in exacerbated bipolar patients: a case series.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000265
Impact of Ramadan fasting on medical and psychiatric health.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000275
High pretreatment cognitive impulsivity predicts response of oppositional symptoms to methylphenidate in patients with attention-deficit hyperactivity disorder/oppositional defiant disorder
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000252
The effectiveness of high-dose escitalopram in the treatment of patients suffering from schizophrenia with comorbid obsessive-compulsive disorder: an open-label study.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000266
Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 2-week, randomized, double-blind, placebo-controlled study
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000271
Switching from clozapine to paliperidone palmitate-3-monthly improved obesity, hyperglycemia and dyslipidemia lowering antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000300
A personal account of depressive illness and its antidepressant treatment
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000273
Lithium and valproate serum level fluctuations within the menstrual cycle: a systematic review
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000253
Reintroduction of quazepam: an update on comparative hypnotic and adverse effects.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000277
Use of cardiovascular and antidiabetic drugs before and after starting with clozapine versus other antipsychotic drugs: a Dutch database study.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000292
Poor performance of the ‘child Reading the Mind in the Eyes Test’ correlates with poorer social-emotional functioning in children with attention-deficit/hyperactivity disorder
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000299
Impact of mental illness on outcomes of outpatients with community-acquired pneumonia
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000245
Effects of antidepressant treatments on health service utilization and medical costs among patients with depression: a nationwide population-based retrospective cohort study in Taiwan.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000262
Addressing clozapine under-prescribing and barriers to initiation: a psychiatrist, advanced practice provider, and trainee survey.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000269
Safety of traditional medicine and natural product supplements in psychiatry.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000279
Clozapine-associated neutropenia in Latin America: incidence report of 5380 Chilean users.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000270
Concomitant use of alcohol and benzodiazepine hypnotics in psychiatric outpatients: a cross-sectional survey.
来源期刊:International clinical psychopharmacologyDOI:10.1097/YIC.0000000000000264
Efficacy of melatonin as an adjunct in the treatment of acute mania: a double-blind and placebo-controlled trial
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000298
Association between electroencephalogram changes and plasma clozapine levels in clozapine-treated patients
来源期刊:International Clinical PsychopharmacologyDOI:10.1097/YIC.0000000000000255

相关文章

2026年3月发布(新锐分区)
大类学科小类学科Top期刊综述期刊
医学3区
PHARMACOLOGY & PHARMACY 药学
3区
PSYCHIATRY 精神病学
4区
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
3区
PSYCHIATRY 精神病学
4区
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学3区
PHARMACOLOGY & PHARMACY 药学
3区
PSYCHIATRY 精神病学
4区